[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360670-105":59,"doc-detail-360670-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","stat3-interference-driven-nanomodulators-reverse-lipid-metabolism-associated-chemoresistance-and-potentiate-metalloimmunotherapy-in-breast-cancer-article","STAT3 interference-driven nanomodulators reverse lipid metabolism-associated chemoresistance and potentiate metalloimmunotherapy in breast cancer - Article","","STAT3 interference-driven nanomodulators NiS@ALB are developed for activable co-delivery of Ni2+ and H2S to trigger metalloimmunotherapy in breast cancer. By suppressing STAT3 signaling-mediated lipid metabolism, the platform sensitizes tumors to chemotherapy while improving immunogenicity. Ni2+ induces pyroptosis and promotes immune-cell mobilization, and the nanoplatform synergizes with chemotherapy to evoke a systemic immune response. Combination with αPD-1 inhibits primary tumor growth and clears distant metastasis through durable anti-tumor immunity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/stat3-interference-driven-nanomodulators-reverse-lipid-metabolism-associated-chemoresistance-and-potentiate-metalloimmunotherapy-in-breast-cancer-article/360670/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/stat3-interference-driven-nanomodulators-reverse-lipid-metabolism-associated-chemoresistance-and-potentiate-metalloimmunotherapy-in-breast-cancer-article/360670.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in breast cancer therapy?","Question",{"text":112,"@type":113},"The study targets persistent STAT3 activation and lipid metabolism alterations that correlate with progression, chemotherapy resistance, and low immunogenicity in the tumor microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does NiS@ALB work to enhance treatment?",{"text":117,"@type":113},"NiS@ALB is an activable nanoplatform for controllable delivery of Ni2+ and H2S. It initiates metalloimmunotherapy by inducing pyroptosis and suppressing STAT3 signaling-mediated lipid metabolism, thereby improving chemosensitivity and tumor immunogenicity.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does combining with αPD-1 matter?",{"text":121,"@type":113},"The combination with αPD-1 synergistically suppresses progression of both primary and metastatic tumors, enhancing systemic anti-tumor immunity beyond chemotherapy alone.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360670,1790229929,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Article  \nSTAT3 interference-driven nanomodulators reverse lipid metabolism-associated chemoresistance and potentiate metalloimmunotherapy in breast cancer  \nAuthors  \nZifan Pei, Yifan Yin, Nailin Yang, ..., Minming Chen, Wei Liu, Liang Cheng  \nCorrespondence  \n[lcheng2@suda.edu.cn](lcheng2@suda.edu.cn)  \nIn brief  \nPei et al. develop an activable nanoplatform NiS@ALB for co-delivery of Ni2+ and H2S to initiate metalloimmunotherapy and modulate STAT3 signaling-mediated lipid metabolism, which synergistically potentiates the chemosensitivity and immunogenicity of breast cancer. The combination with chemotherapy and αPD-1 elicits potent systemic immune response and suppresses breast tumor progression and metastasis.  \n• Ni2+ elicits pyroptosis of tumor cells and initiates metalloimmunotherapy  \n• NiS@ALB synergizes with chemotherapy to activate a systemic immune response  \n• Combination with αPD-1 suppresses primary tumor and eliminates distant metastasis  \nPei et al., 2026, Cell Reports Medicine 7, 102844  \nJune 16, 2026 © 2026 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2026.102844](https://doi.org/10.1016/j.xcrm.2026.102844)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nSTAT3 interference-driven nanomodulators reverse lipid metabolism-associated chemoresistance and potentiate metalloimmunotherapy in breast cancer  \nZifan Pei,1,5 Yifan Yin,2,3,5 Nailin Yang,1,5 Shumin Sun,1 Nan Jiang,4 Fangyi Yu,1 Xiaofen Zhang,1 Jihu Nie,1 Youdong Chen,1 Longxiao Li,1 Jie Wu,1 Fei Gong,1 Minming Chen,1 Wei Liu,2 and Liang Cheng1,6,*  \n1Institute of Functional Nano and Soft Materials (FUNSOM), Biomedical-BasicResearch-Center (BBRC) of Jiangsu Province, Soochow University, 199 Ren’Ai Rd. , Suzhou 215123, China  \n2Department of General Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, China  \n3Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China  \n4Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China  \n5These authors contributed equally  \n6Lead contact  \n*Correspondence: [lcheng2@suda.edu.cn](lcheng2@suda.edu.cn)  \n[https://doi.org/10.1016/j.xcrm.2026.102844](https://doi.org/10.1016/j.xcrm.2026.102844)  \nSUMMARY  \nClinical evidence has suggested that persistent STAT3 activation and alteration in lipid metabolism correlate with pathological progression in patients with breast cancer, driving resistance to chemotherapy. Herein, we show that H2S, an endogenous gas signaling molecule, sensitizes breast cancer to chemotherapy by suppressing STAT3 signaling-mediated lipid metabolism and improves tumor immunogenicity. Moreover, we further identify Ni2+ as immune agonist for potent metalloimmunotherapy. The construction of an activable nanoplatform enables the controllable delivery of metal ions and H2S gas, which triggers pyroptosis and mobilizes multiple immune cells to elicit systemic anti-tumor immunity in combination with chemotherapy. Moreover, the synergy with αPD-1 inhibits the progression of both primary and metastatic tumors. Our work highlights the potential of bioactive gas transmitters and nutrient metal ions for reversing the dual dilemmas of chemoresistance and low immunogenicity in breast cancer and thus provides a nanosensitization strategy to synergize with multiple clinical treatment modalities.  \nINTRODUCTION  \nDuring the past four decades, the incidence of breast cancer has increased alarmingly, which has become the second most widespread and fatal malignancy in females.1 ,2 Currently, chemotherapies based on anthracyclines and paclitaxel remain the cornerstone of clinical treatment for breast cancer.3 However, breast cancer cells develop chemoresistance via various molecular biological mechanisms, eventually leading to recurrence and metastasis, with a five-year survival rate of less than ∼30% in patients with advanced breast cancer.4 ,5 Despite the revolution that immunotherapy ","cbCaih61VHozLsu3","https://ap.wps.com/l/cbCaih61VHozLsu3","pdf",22727681,29,"English","# SUMMARY\n# INTRODUCTION","[{\"question\":\"What problem does the study address in breast cancer therapy?\",\"answer\":\"The study targets persistent STAT3 activation and lipid metabolism alterations that correlate with progression, chemotherapy resistance, and low immunogenicity in the tumor microenvironment.\"},{\"question\":\"How does NiS@ALB work to enhance treatment?\",\"answer\":\"NiS@ALB is an activable nanoplatform for controllable delivery of Ni2+ and H2S. It initiates metalloimmunotherapy by inducing pyroptosis and suppressing STAT3 signaling-mediated lipid metabolism, thereby improving chemosensitivity and tumor immunogenicity.\"},{\"question\":\"Why does combining with αPD-1 matter?\",\"answer\":\"The combination with αPD-1 synergistically suppresses progression of both primary and metastatic tumors, enhancing systemic anti-tumor immunity beyond chemotherapy alone.\"}]","STAT3 interference-driven nanomodulators reverse lipid metabolism-associated chemoresistance and potentiate metalloimmunotherapy in breast cancer - Article | PDF",1790141008,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cdd656deb3d29903e40d95a5ba01c85.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93e26f3b0733547c01dc383aba093840.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7befc587151cf6c4f3a5d5f31f2d8caa.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/706900e03954c05c03a8bb10f03a1f33.webp",980,1272]